These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4341974)

  • 1. Evidence of adrenergic--cholinergic interaction in the central nervous system. II. Dopamine and its analogues.
    Ho AK; Lo HH
    Eur J Pharmacol; 1972 Aug; 19(2):145-50. PubMed ID: 4341974
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 6-hydroxydopamine on an identified dopamine-containing neuron in the central nervous system of Planorbis corneus.
    Berry MS; Pentreath VW; Turner JD; Cottrell GA
    Brain Res; 1974 Aug; 76(2):309-24. PubMed ID: 4367507
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of chronic administration of some cholinergic and adrenergic drugs on the activity of choline acetyltransferase in the optic lobes of the chick brain.
    Mandell AJ; Knapp S
    Neuropharmacology; 1971 Jul; 10(4):513-6. PubMed ID: 5094311
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholinergic and adrenergic effects of atropine and physostigmine on brain chemistry and learned behavior.
    Flynn A
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):173-80. PubMed ID: 4671884
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.
    Breese GR; Traylor TD
    J Pharmacol Exp Ther; 1970 Sep; 174(3):413-20. PubMed ID: 5456173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of facilitation and muscarinic or alpha-adrenergic inhibition of acetylcholine and noradrenaline secretion from peripheral nerves.
    Alberts P
    Acta Physiol Scand Suppl; 1982; 506():1-39. PubMed ID: 6293252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a central noradrenaline receptor stimulation by clonidine.
    Andén NE; Corrodi H; Fuxe K; Hökfelt B; Hökfelt T; Rydin C; Svensson T
    Life Sci; 1970 May; 9(9):513-23. PubMed ID: 4393798
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible behavioural function for noradrenaline--acetylcholine interaction in brain.
    Mason ST; Fibiger HC
    Nature; 1979 Feb; 277(5695):396-6. PubMed ID: 575915
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of the cholinergic system in the central control of thermoregulation in rats.
    Lin MT; Chen FF; Chern YF; Fung TC
    Can J Physiol Pharmacol; 1979 Nov; 57(11):1205-12. PubMed ID: 519522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities in monoamine levels in the central nervous system of the genetically epilepsy-prone rat.
    Jobe PC; Laird HE; Ko KH; Ray T; Dailey JW
    Epilepsia; 1982 Aug; 23(4):359-66. PubMed ID: 6284498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective depletion of cerebral norepinephrine with 6-hydroxydopamine and GBR-12909 in neonatal rat.
    Teicher MH; Barber NI; Reichheld JH; Baldessarini RJ; Finklestein SP
    Brain Res; 1986 Nov; 395(1):124-8. PubMed ID: 2430678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adaptation to the behavioral effects of 6-hydroxydopamine].
    Semenova TP; Tret'iak TM; Grishchenko NI; Smirnova GN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):163-5. PubMed ID: 6404069
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of 1-(o-allylphenoxy)-3-isopropylamino-2-propanol hydrochloride (alprenolol) on the central nervous system of the rat.
    Herman ZS; Kmieciak-Kolada K; Drybański A; Sokola A; Trzeciak H; Chruściel TL
    Psychopharmacologia; 1971; 21(1):66-73. PubMed ID: 4398073
    [No Abstract]   [Full Text] [Related]  

  • 14. Central and peripheral noradrenaline and resistance to extinction.
    Mason ST; Iversen SD
    Physiol Behav; 1978 Jun; 20(6):681-6. PubMed ID: 684106
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of hyperglycemic response to chlorpromazine administered into lateral ventricle in rats. I. Possible role of dopaminergic nervous system.
    Fujimori K; Iwamoto T
    Neuropharmacology; 1974 Apr; 13(4):245-54. PubMed ID: 4853135
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of the catecholaminergic system of the brain in addiction to alcohol (review)].
    Borisov MM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(8):1244-9. PubMed ID: 2864770
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenergic receptors and others. Fourteenth Annual Becton, Dickinson and Company Oscar Schwidetzky Memorial Lecture.
    Ahlquist RP
    Anesth Analg; 1979; 58(6):510-5. PubMed ID: 42329
    [No Abstract]   [Full Text] [Related]  

  • 18. Disorders of the autonomic nervous system. Chapter 2. Relavant aspects of pharmacology.
    Johnson RH; Spaulding JM
    Contemp Neurol Ser; 1974; (11):23-32. PubMed ID: 4141661
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 20. Involvement of alpha-adrenergic receptors at different levels of the central nervous system in the regulation of blood pressure and heart frequency.
    Trolin GG
    Acta Physiol Scand Suppl; 1975; 430():1-41. PubMed ID: 1064288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.